PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me

FDA approved weight loss drugs: the full list and what they cost

Today’s cheapest GLP-1$41/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 18 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved.

Nine prescription drugs carry an FDA label for weight loss in the United States today, and one more is sold over the counter. Four of the nine are GLP-1 medicines: Wegovy, Zepbound, Saxenda and Foundayo. Four are older pills: Qsymia, Contrave, Xenical and phentermine. The ninth, Imcivree, treats rare genetic obesity. This page lists all of them with the words of their own FDA labels, then shows what the ones we track cost today, starting at $41 a month.

8 min read · published November 2026

Studio still life: two unbranded pen injectors crossed at a shallow angle

Key takeaways

  • 1Nine prescription drugs hold an FDA label for weight loss in adults, and orlistat is also sold over the counter as alli.
  • 2Four are GLP-1 medicines: Wegovy and Zepbound as weekly shots, Foundayo as a daily tablet, and Saxenda as a daily shot that Novo Nordisk is discontinuing.
  • 3Four are older and cheaper pills: Qsymia, Contrave, Xenical and phentermine. Imcivree is for rare genetic obesity only.
  • 4Compounded semaglutide and tirzepatide are not FDA approved, whatever a seller's website says.
  • 5Tracked cash programs on our board start at $41 a month, all-in with any verified fee.

Nine prescription drugs carry an FDA label for weight loss in the United States today, and one more is sold over the counter. Four of the nine are GLP-1 medicines, the group that works on the gut hormones that tell your brain you are full. Four are older pills that have been on sale for years. The ninth treats rare genetic forms of obesity. Tracked cash programs on our board start at $41 a month.

An FDA label is the legal statement of what a drug is approved to treat. Every row below quotes the drug's own label, so you can see what the FDA actually agreed to, not what an advert says.

The full list of FDA approved weight loss drugs

Drug (active ingredient)How you take itWhat its FDA label coversPrice we track
Zepbound (tirzepatide)Weekly injection"to reduce excess body weight and maintain weight reduction long term" in adults, and "to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity"1Zepbound programs
Wegovy (semaglutide)Weekly injection, or a daily tabletLong term weight loss, plus lowering the risk of "major adverse cardiovascular (CV) events" in adults with heart disease and obesity or overweight2Wegovy programs
Foundayo (orforglipron)Daily tabletLong term weight loss "in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition"4Foundayo guide
Saxenda (liraglutide)Daily injectionLong term weight loss in adults, and in children aged 12 and older above a set body weight3Novo Nordisk is discontinuing it13
Qsymia (phentermine and topiramate)Daily capsuleLong term weight loss in adults, and in children aged 12 and older with obesity5Not on our board
Contrave (naltrexone and bupropion)Tablets, morning and eveningLong term weight loss "in adults with obesity or overweight in the presence of at least one weight-related comorbid condition"6Not on our board
Xenical (orlistat)Capsule with mealsLong term weight loss in adults, and in "pediatric patients aged 12 years and older with obesity"7Not on our board
Phentermine (Lomaira and other brands)TabletA "short-term (a few weeks)" aid to weight reduction alongside diet and exercise8Not on our board
Imcivree (setmelanotide)Daily injectionWeight loss in people with named genetic or acquired causes of obesity, such as "acquired hypothalamic obesity"9Not on our board
alli (orlistat, over the counter)Capsule with meals"for weight loss in overweight adults, 18 years and older, when used along with a reduced-calorie and low-fat diet"10Sold in pharmacies without a prescription

Two of those rows are the same drug at different strengths. Xenical is the prescription version of orlistat and alli is the version you can buy yourself.710

The four GLP-1 drugs

These are the ones most people mean when they search for weight loss drugs. They copy a gut hormone your body already makes, which slows the stomach and lowers appetite.

  • Zepbound is a weekly shot. Its label also covers obstructive sleep apnea in adults with obesity, which no other weight loss drug can claim.1
  • Wegovy comes as a weekly shot and as a daily tablet. Its label adds heart protection for adults who already have heart disease.2
  • Foundayo is the newest, and the first GLP-1 for weight loss that is a plain daily tablet rather than an injection.4
  • Saxenda is the oldest, a daily shot. Novo Nordisk says the last shipments to wholesalers happen "in late January 2027", and that the decision "is not the result of any safety or quality-related concerns".13

Our ranking of the programs that sell these, cheapest first, is on the GLP-1 board. If you want the evidence on which one takes off more weight, read the best GLP-1 for weight loss.

The older pills, and why they still matter

Qsymia, Contrave, Xenical and phentermine came first, and they are far cheaper. None of them matches the newer drugs for average weight loss, and each carries its own cautions, so this is a conversation to have with a prescriber.

Two of them are now generic, and the prices are small. Under the federal survey of what US pharmacies actually pay, a generic orlistat capsule came to about $7.07, and a generic phentermine capsule to about 10 cents, in the data effective 21 October 2026.1112 What you pay at the counter is higher, because a pharmacy adds its own margin and fee.

Qsymia's own label notes a limit worth knowing: "The effect of QSYMIA on cardiovascular morbidity and mortality has not been established."5 Phentermine on its own is labelled for short term use only, "a few weeks", which makes it a poor fit for a long plan.8

What these drugs cost

Brand prices through insurance vary by plan, so the honest number for most people is the cash price. Here is what the programs we track charge today, all-in with any verified membership fee.

If you have coverage, start with GLP-1 cost with insurance. If you do not, GLP-1s without insurance walks through the cash routes.

What is not FDA approved

Compounded semaglutide and compounded tirzepatide are made for one patient by a pharmacy. They are legal under set conditions, but they are not FDA approved products. The FDA says plainly that "unapproved versions do not undergo FDA's review for safety, effectiveness and quality before they are marketed".14

Research compounds sold online, such as retatrutide, have no FDA approval for any use. Our page on whether compounded semaglutide is safe explains the difference in full.

Drugs approved for diabetes that doctors also use

Ozempic, Mounjaro and Rybelsus hold FDA labels for type 2 diabetes, not weight loss. They contain the same active ingredients as Wegovy, Zepbound and the Wegovy tablet. Prescribing them for weight alone is off-label, which is legal but often not covered. See Ozempic for weight loss and Mounjaro for weight loss.

How to choose one

  1. Start with what your plan covers. A covered drug almost always beats a better drug you cannot afford to keep taking.
  2. Match the drug to your other conditions. Heart disease, sleep apnea and diabetes each point to a different label.
  3. Be honest about needles. Two options are daily tablets, and sticking with the treatment matters more than the trial averages.
  4. Check the all-in price. Some programs add a membership fee on top of the medicine, which our board already includes.
  5. Ask about stopping. Weight usually returns when treatment stops, so ask what the plan is after the first year.
Sources14
  1. Zepbound (tirzepatide) prescribing information, DailyMed: indications read November 2026“to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. ... to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.” ↩
  2. Wegovy (semaglutide) prescribing information, DailyMed: indications for the injection and the tablets read November 2026“WEGOVY injection is indicated in combination with a reduced calorie diet and increased physical activity: ... to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight. ... WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity:” ↩
  3. Saxenda (liraglutide) prescribing information, DailyMed: indications read November 2026“SAXENDA is indicated in combination with a reduced calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: ... Adults with overweight in the presence of at least one weight-related comorbid condition.” ↩
  4. Foundayo (orforglipron) prescribing information, DailyMed: indications and limitations of use read November 2026“is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. ... Concomitant use with another GLP-1 receptor agonist is not recommended.” ↩
  5. Qsymia (phentermine and topiramate) prescribing information, DailyMed: indications and limitations of use read November 2026“QSYMIA is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: ... The effect of QSYMIA on cardiovascular morbidity and mortality has not been established.” ↩
  6. Contrave (naltrexone and bupropion) prescribing information, DailyMed: indications read November 2026“CONTRAVE is indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition.” ↩
  7. Xenical (orlistat) prescribing information, DailyMed: indications read November 2026“XENICAL is indicated in combination with a reduced calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in: ... adults and pediatric patients aged 12 years and older with obesity.” ↩
  8. Lomaira (phentermine hydrochloride) prescribing information, DailyMed: indications read November 2026“tablets are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of exogenous obesity” ↩
  9. Imcivree (setmelanotide) prescribing information, DailyMed: indications read November 2026“IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged ... 4 years and older with acquired hypothalamic obesity (HO) ... 2 years and older with syndromic or monogenic obesity due to:” ↩
  10. alli (orlistat) drug facts, DailyMed: the over-the-counter use statement read November 2026“Use for weight loss in overweight adults, 18 years and older, when used along with a reduced-calorie and low-fat diet” ↩
  11. CMS, NADAC (National Average Drug Acquisition Cost), generic orlistat, as of 11 November 2026 read November 2026“"ndc_description":"ORLISTAT 120 MG CAPSULE","ndc":"61269056590","nadac_per_unit":"7.06713","effective_date":"2026-10-21","pricing_unit":"EA"” ↩
  12. CMS, NADAC, generic phentermine, as of 11 November 2026 read November 2026“"ndc_description":"PHENTERMINE 15 MG CAPSULE","ndc":"10702002601","nadac_per_unit":"0.10340","effective_date":"2026-10-21","pricing_unit":"EA"” ↩
  13. Novo Nordisk (NovoMedLink), Saxenda discontinuation notice read November 2026“last shipments to wholesalers taking place in late January 2027. As more alternative FDA-approved treatment options have become available and the number of patients using Saxenda ® has continued to decline, Novo Nordisk has made the strategic portfolio decision to discontinue the brand in the US. This decision is not the result of any safety or quality-related concerns.” ↩
  14. FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss read November 2026“This can be risky for patients, as unapproved versions do not undergo FDA’s review for safety, effectiveness and quality before they are marketed.” ↩

Common questions

How many weight loss drugs has the FDA approved?

Nine prescription drugs hold an FDA label for weight loss in the United States: Zepbound, Wegovy, Foundayo, Saxenda, Qsymia, Contrave, Xenical, phentermine and Imcivree. Orlistat, the ingredient in Xenical, is also sold over the counter as alli.

Which FDA approved weight loss drug works best?

In the published trials, the GLP-1 drugs lead by a wide margin, and tirzepatide (Zepbound) averaged more weight loss than semaglutide (Wegovy). Averages are not promises, and the right drug is the one that fits your health and that you can keep paying for. Our guide to the best GLP-1 for weight loss sets the trials side by side.

Is compounded semaglutide FDA approved?

No. Compounded semaglutide is made by a pharmacy for an individual patient and is not an FDA approved product. The FDA warns that unapproved versions do not go through its review for safety, effectiveness and quality before they are sold.

What is the cheapest FDA approved weight loss drug?

Generic phentermine and generic orlistat are by far the cheapest, which is why some clinicians still start there. Among the GLP-1 drugs, cash programs on our board start at $41 a month, all-in with any verified fee.

Is Ozempic approved for weight loss?

No. Ozempic holds an FDA label for type 2 diabetes. The same ingredient, semaglutide, is approved for weight loss under the name Wegovy. A prescriber may still prescribe Ozempic for weight off-label, but insurers rarely cover that use.

Is Saxenda being discontinued?

Yes. Novo Nordisk has given notice that it will discontinue Saxenda in the US, with the last shipments to wholesalers in late January 2027. The company says the decision is not the result of any safety or quality concerns.

Choosing a program? See our ranking of the best online GLP-1 programs for every partner side by side, or the cheapest GLP-1 page for price alone.

Next steps

Read next